Search - tctmd.com

Displaying 741 - 760 of 806

Sort: Relevancy | Date

Presentation

Stent Thrombosis with Everolimus-Eluting Stents

Presenter: T. Palmerini

June 14, 2012

Presentation TCT Russia 2012

Evidence Based Device Selection (Stents, Thrombectomy, etc.) for Primary PCI

Presenter: Petr Kala

May 28, 2012

Presentation

Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion

Presenter: 167498|Scott Denardo

May 24, 2012

Presentation EuroPCR 2012

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

Presenter: 168190|Lorenz Raber

May 18, 2012

Presentation TCT Mediterranean 2012

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Presenter: C. Moretti

May 04, 2012

Presentation TCT Mediterranean 2012

Bioabsorbable Stents and Polymers: Is It Prime Time?

Presenter: Eugenia Nikolsky

May 04, 2012

Presentation TCTAP 2012

Update of Dedicated Bifurcation Stents

Presenter: Martin B. Leon

April 26, 2012

Presentation TCT Russia 2012

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Presenter: Gregg W. Stone

April 26, 2012

Presentation Fellows 2012

Zotarolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Presenter: David Kandzari

April 21, 2012

Presentation Fellows 2012

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

Presenter: Juan Granada

April 21, 2012

Presentation Fellows 2012

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

Presenter: Issam Moussa

April 21, 2012

Presentation Fellows 2012

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Presenter: Gregg Stone

April 21, 2012

Presentation

Long-term (more than 10 years) Clinical Outcomes of First-in-Man Biodegradable PLLA Coronary Stents

Presenter: S. Nishio

April 16, 2012

Presentation GI2 2012

Thrombo Aspiration and Covered Stents

Presenter: Ron Waksman

April 13, 2012

Presentation ACC 2012

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Presenter: Gregg Stone

March 28, 2012

Presentation ACC 2012

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Presenter: Robert A. Byrne

March 24, 2012

Presentation PCI Outcomes 2012

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Presenter: Gregg W. Stone

March 23, 2012

Presentation CTO 2012

Use of Taxus Element Stents for the Angioplasty of a Distal Left Main Complex Lesion with Ostial CTO of the LAD

Presenter: Philippe Durand

February 24, 2012

Presentation CTO 2012

One Stent vs Two Stents: Evidence-Based Medicine and Cath Lab Practicalities

Presenter: David Kandzari

February 22, 2012

Presentation CTO 2012

Dedicated Left Main Bifurcation Stents 2: Experience with the Tryton

Presenter: Yaron Almagor

February 22, 2012

Advertisement

Stent Thrombosis with Everolimus-Eluting Stents

Evidence Based Device Selection (Stents, Thrombectomy, etc.) for Primary PCI

Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

DES Pipeline: The Evolution of Everolimus Eluting Stents Utilizing Platinum Chromium Alloy

Bioabsorbable Stents and Polymers: Is It Prime Time?

Update of Dedicated Bifurcation Stents

Lessons from Pooled Data with Xience Everolimus-Eluting Stents

Zotarolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Next-Generation Technologies: Bioabsorbable Stents/Polymers, Drug-Eluting Balloons, and More

First-Generation Drug-Eluting Stents: The Good, the Bad, and the Ugly

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Long-term (more than 10 years) Clinical Outcomes of First-in-Man Biodegradable PLLA Coronary Stents

Thrombo Aspiration and Covered Stents

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Controversy 1: Current Drug-Eluting Stents Are Not Only More Effective But Are Safer Than Bare Metal Stents and Should Be Used in more than 90% of (Stented) Patients

Use of Taxus Element Stents for the Angioplasty of a Distal Left Main Complex Lesion with Ostial CTO of the LAD

One Stent vs Two Stents: Evidence-Based Medicine and Cath Lab Practicalities

Dedicated Left Main Bifurcation Stents 2: Experience with the Tryton

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content